Literature DB >> 8536725

Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis.

J E Hoppe1, T Tschirner.   

Abstract

Antimicrobial susceptibility testing of the fastidious species Bordetella pertussis and Bordetella parapertussis is not standardized. In an attempt to find the optimal medium for agar dilution testing, the activity of erythromycin against Bordetella pertussis and Bordetella parapertussis (34 isolates each) was assessed using homologous broth/agar combinations of Bordet-Gengou, charcoal, Iso-Sensitest (Oxoid) and Mueller-Hinton media. Each medium was supplemented with 5% and 20% whole defibrinated horse blood. Mueller-Hinton medium supplemented with 5% horse blood performed best overall.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8536725     DOI： 10.1007/bf01690992

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  20 in total

1.  In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.

Authors:  J E Hoppe; C G Simon
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 2.  In vitro simulation of in vivo conditions: physical state of the culture medium.

Authors:  V Lorian
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

3.  Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.

Authors:  J E Hoppe; A Eichhorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

4.  Failure of charcoal-horse-blood broth with cephalexin to significantly increase rate of Bordetella isolation from clinical specimens.

Authors:  J E Hoppe; A Weiss; S Wörz
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

5.  The effect of charcoal on MICs for Legionella.

Authors:  J Barker; I D Farrell
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

6.  Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.

Authors:  M E Appleman; T L Hadfield; J K Gaines; R E Winn
Journal:  Diagn Microbiol Infect Dis       Date:  1987-10       Impact factor: 2.803

Review 7.  Antimicrobial susceptibility of Bordetella pertussis (Part I).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

8.  Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem.

Authors:  R M Bannatyne; R Cheung
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

9.  Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.

Authors:  G Zackrisson; J E Brorson; B Björnegård; B Trollfors
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

10.  In vitro activity of flomoxef in comparison to other cephalosporins.

Authors:  C Simon; M Simon; C Plieth
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553
View more
  7 in total

Review 1.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

2.  In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).

Authors:  J E Hoppe; A Bryskier
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Update of epidemiology, diagnosis, and treatment of pertussis.

Authors:  J E Hoppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

4.  Susceptibility testing of Bordetella pertussis.

Authors:  J E Hoppe
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem.

Authors:  J E Hoppe; E Rahimi-Galougahi; G Seibert
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Comparison of three media for agar dilution susceptibility testing of Bordetella pertussis using six antibiotics.

Authors:  J E Hoppe; T Paulus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

7.  In Vitro Activity of Solithromycin against Bordetella pertussis, an Emerging Respiratory Pathogen.

Authors:  Dwight J Hardy; David Vicino; Prabhavathi Fernandes
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.